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low dose ASA alone, the multivariate adjusted significance was 0.01. Conclusion: In a
healthy population without known coronary disease, after controlling for major risk fac-
tors, the use of ASA and a statin alone remains significantly associated with lower levels
of inflammation, and importantly the combination of both a statin and aspirin is a particu-
larly strong independent predictor of lower levels of hs-CRP. These findings suggest that
daily statin and aspirin therapy combined may be particularly potent in reducing inflam-
mation in high risk individuals who have not yet had a clinical coronary event.
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Background: Lack of platelet aggregation response to aspirin resistance (AR) has been
reported in 5-30% of patients. Using strict criteria for AR, we have shown a three fold
increased risk of death, MI and CVA. The underlying mechanisms for the variable effect
of aspirin remain unclear and are likely multi-factorial. Polymorphisms in platelet surface
receptors may alter the response of platelets to pharmacologic agents and play a role in
aspirin sensitivity.
Methods: We examined 7 candidate single nucleotide polymorphisms in the COX-1,
COX-2, GPIIIa, and P2Y1(P2RY1) genes in 332 patients on aspirin with a history of MI
from the Gene Quest 2 database. Aspirin resistance was assessed using optical aggre-
gation in response to arachidonic acid and ADP. Aspirin sensitive (aggregation <20%)
and resistant (>20%) subjects were compared using multiple logistic regression. DNA
was genotyped using standard PCR techniques.
Results: In the study population, 235(71%) were classified as aspirin sensitive and
95(29%) were classified as aspirin resistant. Clinical comparisons between aspirin sensi-
tive and aspirin resistant patients revealed a significant difference between the groups in
age (63.3 y/68.4 y), HDL cholesterol (39 mg/dl/35.6 mg/dl), and incidence of diabetes
(22%/37%). Using logistic regression analysis, patients with the P2RY1 C/T893 genotype
displayed a statistically significant 3-fold higher risk of aspirin resistance over those with
the P2RY1 C/C893 genotype. The risk of aspirin resistance remained even after adjust-
ing for the above confounding variables: Adjusted OR 2.72 (95% C.I. 1.12, 6.57). Single
nucleotide polymorphisms in other candidate genes were not associated with aspirin
resistance.
Conclusions: There are demographic differences between aspirin sensitive and aspirin
resistant patients which are in agreement with previous reports. After controlling for these
variables, the P2RY1 C/T893 polymorphism is associated with decreased platelet
responsiveness to aspirin. Polymorphisms in the P2Y1 receptor gene may provide a
genetic link in the variable clinical responsiveness of patients to aspirin and requires con-
firmation and elucidation of the mechanism.
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Background. Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of NO
synthase. In human subjects, its levels are related to endothelial dysfunction and the pro-
gression of carotid atherosclerosis. In patients with end-stage renal disease, ADMA is
prospectively associated with the risk of major cardiovascular events and death.
It was the aim of the CARDIAC study (Coronary Artery Risk Determination investigating
the Influence of ADMA Concentration) to assess the relationship between ADMA con-
centration and the risk for coronary heart disease (CHD) in a large population including
subjects with a broad range of established coronary risk factors of both sexes and with
normal renal function. We also studied the relationship between ADMA and traditional
risk factors in risk determination.
Methods. 408 patients with established CHD and 408 controls matched for age and sex
were enrolled. Besides traditional risk factors, plasma levels of ADMA and its biologically
inactive regioisomer, symmetric dimethylarginine (SDMA), and L-arginine were deter-
mined.
Results. CHD patients had significantly higher ADMA plasma concentration than controls
(median, 0.91 vs. 0.70 µmol/L; p<0.0001). ADMA was an independent predictive factor
for the risk of CHD, whereas SDMA was not associated with CHD. ADMA levels signifi-
cantly increased with increasing number of established cardiovascular risk factors
present (p<0.01). The presence of hypertension was associated with significantly higher
ADMA levels (median, 0.95 vs. 0.87 µmol/l; p<0.05), whereas hypercholesterolemia was
associated with lower ADMA (0.85 vs. 1.03 µmol/l; p<0.05; probably due to the high rate
of treated hypercholesterolemia), and diabetes mellitus had no significant effect on
ADMA. Former smokers had higher ADMA than current smokers or non-smokers (1.16
vs. 0.70 and 0.88 µmol/l, respectively; p<0.01).
Conclusions. The present data show for a large group of subjects of both sexes and with
a broad range of established coronary risk factors that ADMA is an independent marker
of CHD. Thus, determination of ADMA may help to identify patients at risk for coronary
events beyond currently established risk factors.
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Backgroud: Arterial stiffness is associated with cardiovascular risk factors and is an
independent predictor of cardiovascular disease and events even after adjusting for other
traditional risk factors. However, no data are available regarding the relationship of arte-
rial stiffness in young adults to different risk factors measured in childhood, adulthood, or
as a cumulative burden from childhood to adulthood.
Methods: The study sample included 839 young adults (72% whites, 44% males) aged
24 to 44 years who had at least four measurements of traditional risk factors including
body mass index (BMI), systolic blood pressure, low- and high-density lipoprotein (LDL
and HDL) cholesterols, and triglycerides since childhood. The average follow-up period
was 26.5 years. Brachial to ankle pulse wave velocity (baPWV) by oscillometric method
was used as a measure of arterial stiffness. Cumulative burden of risk factors since child-
hood was measured as area under the curve divided by follow-up years.
Results: Males vs females and black vs whites had higher levels of baPWV (P<0.001).
Systolic blood pressure, BMI, and HDL cholesterol measured in childhood, all the risk
factors measured in adulthood, and cumulative burdens of systolic blood pressure, trig-
lycerides, BMI, and HDL cholesterol were significant risk factors for baPWV in young
adults in univariate analyses. In multiple regression analyses, childhood systolic blood
pressure, adulthood systolic blood pressure and triglycerides, and cumulative burdens of
systolic blood pressure and triglycerides since childhood were significant and indepen-
dent risk factors for baPWV in young adults.
Conclusion: These results indicate that among the traditional cardiovascular risk factors,
systolic blood pressure measured either in childhood, adulthood, or as a cumulative bur-
den since childhood is a consistent predictor of arterial stiffness in young adults, and
underscores its importance in the process of arterial stiffening.
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Background: Serum inflammatory markers such as C-reactive protein have been shown
to predict cardiovascular morbidity and mortality. Anemia is emerging as a risk factor for
morbidity and mortality in patients presenting with acute myocardial infarction or heart
failure, and other WISE data indicates that lower hemoglobin levels are significantly
associated with worse cardiovascular outcomes. However, the relationship between
serum inflammatory markers and hemoglobin levels in women presenting with chest pain
is not known.
Methods: As part of the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation
(WISE), we collected data including baseline hemoglobin level, high sensitivity C-reactive
protein (CRP), IL-6, and TNF-alpha levels in 602 women referred for coronary angiogra-
phy to evaluate suspected ischemia. We then compared the hemoglobin levels with
serum inflammatory marker levels.
Results: Of the women enrolled, the mean age was 58.0 + 11.7 yrs, and 35% had angio-
graphic CAD stenoses of >50%, 26% had diabetes, 58% had hypertension, 54% had
dyslipidemia, and 20% were current smokers. As hemoglobin levels increased, serum
inflammatory marker levels including CRP (p=0.05), IL-6 (p=0.005), and TNF-alpha
(p=0.009) decreased. A hemoglobin <12 g/dL was also associated with significantly
higher levels of CRP (p=0.02), IL-6 (p<0.001), and TNF-alpha (p=0.006). After adjusting
for waist/hip ratio, lipid levels, statin use, ACE-inhibitor use, aspirin or other antiplatelet
medication use, and angiographic CAD, hemoglobin <12g/dL was associated with
increased CRP (p=0.07), IL-6 (p< 0.01), TNF-alpha (p<0.01).
Conclusions: Serum inflammatory markers are inversely related to hemoglobin levels in
this population of women evaluated for suspected ischemia. Underlying inflammation
may contribute to both decreased hemoglobin levels and increased cardiovascular mor-
bidity and mortality found in this population of women.
